Serum malondialdehyde, monocyte chemoattractant protein-1, and vitamin C levels in wet type age-related macular degeneration patients
dc.authorid | Sari, Ismail/0000-0003-3732-2102 | |
dc.contributor.author | Zor, Ramazan Kursad | |
dc.contributor.author | Ersan, Serpil | |
dc.contributor.author | Kucuk, Erkut | |
dc.contributor.author | Yildirim, Gamze | |
dc.contributor.author | Sari, Ismail | |
dc.date.accessioned | 2024-11-07T13:31:33Z | |
dc.date.available | 2024-11-07T13:31:33Z | |
dc.date.issued | 2020 | |
dc.department | Niğde Ömer Halisdemir Üniversitesi | |
dc.description.abstract | Purpose: The purpose of this study was to investigate the serum levels of malondialdehyde (MDA) which is a marker of oxidative stress, monocyte chemoattractant protein-1 (MCP-1) which has an important role in inflammation, and vitamin C which has antioxidant properties in patients with wet age-related macular degeneration (wAMD). Methods: Thirty patients with wAMD were included in the study and serum levels of MDA, MCP-1, and vitamin C were compared with healthy participants (n = 30). Serum vitamin C and MDA levels were measured using a spectrophotometric method. Serum MCP-1 levels were determined by the ELISA method. Results: MCP-1 and MDA levels were higher in patients with wAMD compared with the control group (p < 0.05). Serum vitamin C levels were lower in patients with wAMD compared with the control group (p < 0.05). Conclusions: The increase in the MCP-1 levels in patients with wAMD may be associated with increased inflammation in wAMD. Decreased serum vitamin C and elevated MDA levels in patients with wAMD suggest increased oxidative stress in wAMD patients. These results indicate that the increased oxidative stress and inflammation can play a role in the pathogenesis of wAMD. | |
dc.identifier.doi | 10.1177/2515841420951682 | |
dc.identifier.issn | 2515-8414 | |
dc.identifier.pmid | 33062929 | |
dc.identifier.scopus | 2-s2.0-85104536262 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.uri | https://doi.org/10.1177/2515841420951682 | |
dc.identifier.uri | https://hdl.handle.net/11480/14918 | |
dc.identifier.volume | 12 | |
dc.identifier.wos | WOS:000576394200001 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Sage Publications Ltd | |
dc.relation.ispartof | Therapeutic Advances in Ophthalmology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241106 | |
dc.subject | age-related macular degeneration | |
dc.subject | choroidal neovascularization | |
dc.subject | inflammation | |
dc.subject | malondialdehyde | |
dc.subject | monocyte chemoattractant protein-1 | |
dc.subject | oxidative stress | |
dc.title | Serum malondialdehyde, monocyte chemoattractant protein-1, and vitamin C levels in wet type age-related macular degeneration patients | |
dc.type | Article |